Coagulation Dysfunction Criteria in Critically Ill Children: The PODIUM Consensus Conference.
Journal
Pediatrics
ISSN: 1098-4275
Titre abrégé: Pediatrics
Pays: United States
ID NLM: 0376422
Informations de publication
Date de publication:
01 01 2022
01 01 2022
Historique:
accepted:
24
09
2021
entrez:
31
12
2021
pubmed:
1
1
2022
medline:
23
2
2022
Statut:
ppublish
Résumé
Previous criteria for coagulation dysfunction in critically ill children were based mainly on expert opinion. To evaluate current evidence regarding coagulation tests associated with adverse outcomes in children to inform criteria for coagulation dysfunction during critical illness. Electronic searches of PubMed and Embase were conducted from January 1992 to January 2020 by using a combination of medical subject heading terms and text words to define concepts of coagulation dysfunction, pediatric critical illness, and outcomes of interest. Studies were included if critically ill children with coagulation dysfunction were evaluated, if performance characteristics of assessment and/or scoring tools to screen for coagulation dysfunction were evaluated, and if outcomes related to mortality or functional status, organ-specific outcomes, or other patient-centered outcomes were assessed. Data were abstracted from each eligible study into a standard data extraction form, along with risk of bias assessment, by a task force member. The systematic review supports the presence of at least 2 of the following criteria reflecting coagulation dysfunction in the absence of liver dysfunction: platelet count <100 000 cells per μL, international normalized ratio >1.5, fibrinogen level <150 mg/dL, and D-dimer value above 10 times the upper limit of normal, or above the assay's upper limit of detection if this limit is below 10 times the upper limit of normal. The proposed criteria for coagulation dysfunction are limited by the available evidence and will require future validation. Validation of the proposed criteria and identified scientific priorities will enhance our understanding of coagulation dysfunction in critically ill children.
Identifiants
pubmed: 34970670
pii: 184276
doi: 10.1542/peds.2021-052888L
doi:
Substances chimiques
Fibrin Fibrinogen Degradation Products
0
fibrin fragment D
0
Fibrinogen
9001-32-5
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
S79-S83Investigateurs
Melania M Bembea
(MM)
Michael Agus
(M)
Ayse Akcan-Arikan
(A)
Peta Alexander
(P)
Rajit Basu
(R)
Tellen D Bennett
(TD)
Desmond Bohn
(D)
Ann-Marie Brown
(AM)
Joseph A Carcillo
(JA)
Paul Checchia
(P)
Jill Cholette
(J)
Ira M Cheifetz
(IM)
Timothy Cornell
(T)
Allan Doctor
(A)
Michelle Eckerle
(M)
Simon Erickson
(S)
Reid W D Farris
(RWD)
Julie C Fitzgerald
(JC)
Dana Y Fuhrman
(DY)
John S Giuliano Jr
(JS)
Kristin Guilliams
(K)
Michael Gaies
(M)
Stephen M Gorga
(SM)
Mark Hall
(M)
Mary Hartman
(M)
Amanda B Hassinger
(AB)
Sharon Y Irving
(SY)
Howard Jeffries
(H)
Philippe Jouvet
(P)
Sujatha Kannan
(S)
Robinder G Khemani
(RG)
Niranjan Kissoon
(N)
Jacques Lacroix
(J)
Peter Laussen
(P)
Francis Leclerc
(F)
Jan Hau Lee
(JH)
Stephane Leteurtre
(S)
Katie Lobner
(K)
Patrick J McKiernan
(PJ)
Kusum Menon
(K)
Jennifer A Muszynski
(JA)
Folafoluwa Odetola
(F)
Nazima Pathan
(N)
Richard W Pierce
(RW)
Jose Pineda
(J)
Jose M Prince
(JM)
Karen A Robinson
(KA)
Courtney M Rowan
(CM)
Lindsay M Ryerson
(LM)
L Nelson Sanchez-Pinto
(LN)
Luregn J Schlapbach
(LJ)
David T Selewski
(DT)
Lara S Shekerdemian
(LS)
Dennis Simon
(D)
Lincoln S Smith
(LS)
James E Squires
(JE)
Robert H Squires
(RH)
Scott M Sutherland
(SM)
Yves Ouellette
(Y)
Michael C Spaeder
(MC)
Vijay Srinivasan
(V)
Marie E Steiner
(ME)
Robert C Tasker
(RC)
Ravi Thiagarajan
(R)
Neal Thomas
(N)
Pierre Tissieres
(P)
Chani Traube
(C)
Marisa Tucci
(M)
Katri V Typpo
(KV)
Mark S Wainwright
(MS)
Shan L Ward
(SL)
R Scott Watson
(RS)
Scott Weiss
(S)
Jane Whitney
(J)
Doug Willson
(D)
James L Wynn
(JL)
Nadir Yehya
(N)
Jerry J Zimmerman
(JJ)
Informations de copyright
Copyright © 2021 by the American Academy of Pediatrics.
Déclaration de conflit d'intérêts
FINANCIAL DISCLOSURE: The authors have indicated they have no financial relationships relevant to this article to disclose.